Drug utilization, clinical and economic outcomes of patients with osteoarthritis of the hip and/or knee treated with long-term use of traditional NSAIDs, topical NSAIDs, and COX-2 inhibitors

References

• Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington DC: National Academics Press, 2011.
   Google Scholar
• Centers for Disease Control and Prevention. Osteoarthritis (OA). Available at: https://www.cdc.gov/arthritis/basics/osteoarthritis.htm.
   Google Scholar
• Nüesch E, Dieppe P, Reichenbach S, et al. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011;342(2):d1165–d1165.
   PubMed Web of Science ®Google Scholar
• Hawker GA, Croxford R, Bierman AS, et al. All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study. PLOS One. 2014;9(3):e91286.
   PubMed Web of Science ®Google Scholar
• Calders P, Van Ginckel A. Presence of comorbidities and prognosis of clinical symptoms in knee and/or hip osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2018;47(6):805–813.
   PubMed Web of Science ®Google Scholar
• Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;37 Suppl 120(5):3–6.
   PubMed Web of Science ®Google Scholar
• Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American college of rheumatology/arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2020;72(2):149–162.
   PubMed Web of Science ®Google Scholar
• da Costa BR, Reichenbach S, Keller N, et al. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2017;390(10090):e21–e33.
   PubMed Web of Science ®Google Scholar
• Bhala N, Emberson J, Merhi A, et al. Coxib and traditional NSAID trialists’(CNT) collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–779.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Husni ME, Wolski KE, et al. Differences in safety of nonsteroidal antiinflammatory drugs in patients with osteoarthritis and patients with rheumatoid arthritis: a randomized clinical trial. Arthritis Rheumatol. 2018;70(4):537–546.
   PubMed Web of Science ®Google Scholar
• Taylor SD, Everett SV, Taylor TN, et al. A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control. Open Access Rheumatol. 2013;5:69–76.
   PubMedGoogle Scholar
• Nissen SE, Yeomans ND, Solomon DH, et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med. 2016;375(26):2519–2529.
   PubMed Web of Science ®Google Scholar
• Cooper C, Chapurlat R, Al-Daghri N, et al. Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: what does the literature say? Drugs Aging. 2019;36(Suppl 1):15–24.
   PubMed Web of Science ®Google Scholar
• Ebata-Kogure N, Murakami A, Nozawa K, et al. Treatment and healthcare cost among patients with hip or knee osteoarthritis: a cross-sectional study using a real-world claims database in Japan between 2013 and 2019. Clin Drug Investig. 2020;40(11):1071–1084.
   PubMed Web of Science ®Google Scholar
• Sakai R, Cho SK, Jang EJ, et al. International descriptive study for comparison of treatment patterns in patients with knee osteoarthritis between Korea and Japan using claims data. Int J Rheum Dis. 2019;22(11):2052–2058.
   PubMed Web of Science ®Google Scholar
• Silverman S, et al. The clinical and economic burden of long-term prescription NSAID use among patients with osteoarthritis in a commercially-insured population in the United States. Forthcoming. J Health Econ Outcomes Res. 2022.
   PubMedGoogle Scholar
• Xie F, Kovic B, Jin X, et al. Economic and humanistic burden of osteoarthritis: a systematic review of large sample studies. PharmacoEconomics. 2016;34(11):1087–1100.
   PubMed Web of Science ®Google Scholar
• Klinge SA, Sawyer GA. Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review. Phys Sportsmed. 2013;41(2):64–74.
   PubMed Web of Science ®Google Scholar
• Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–1589.
   PubMed Web of Science ®Google Scholar
• van Dijk GM, Veenhof C, Schellevis F, et al. Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or knee. BMC Musculoskelet Disord. 2008;9:95.
   PubMed Web of Science ®Google Scholar
• Arden NK, Perry TA, Bannuru RR, et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2021;17(1):59–66.
   PubMed Web of Science ®Google Scholar
• Noble SL, King DS, Olutade JI. Cyclooxygenase-2 enzyme inhibitors: place in therapy. Am Fam Physician. 2000;61(12):3669–3676.
   PubMed Web of Science ®Google Scholar
• OptumHealth Care Solutions Inc. Employer Claims Database, Q1-2012 -Q1-2017. Available from: https://www.optum.com/business/solutions/data-analytics/data/real-world-data-analytics-a-cpl/claims-data.html
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
   PubMed Web of Science ®Google Scholar
• Bureau of Labor Statistics, “Measuring Price Change in the CPI: Medical Care,” https://www.bls.gov/cpi/factsheets/medical-care.htm#:∼:text=Medical%20care%20services%2C%20the%20larger,and%20medical%20equipment%20and%20supplies.
   Google Scholar
• Callhoff J, Albrecht K, Redeker I, et al. Disease burden of patients with osteoarthritis: results of a cross-sectional survey linked to claims data. Arthritis Care Res. 2020;72(2):193–200.
   PubMed Web of Science ®Google Scholar
• Varga Z, Sabzwari SRA, Vargova V. Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue. Cureus. 2017;9(4):e1144.
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Scarpignato C, Holmgren E, et al. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018;154(3):500–514.
   PubMed Web of Science ®Google Scholar
• Allen KD, Golightly YM. State of the evidence. Curr Opin Rheumatol. 2015;27(3):276–283.
   PubMed Web of Science ®Google Scholar
• Fairweather J, Jawad AS. Cardiovascular risk with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): the urological perspective. BJU Int. 2012;110(11):E437.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Cheungpasitporn W, Crowson CS, et al. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies. Eur J Intern Med. 2015;26(4):285–291.
   PubMed Web of Science ®Google Scholar
• Gore M, Sadosky A, Leslie D, et al. Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis. Clin Ther. 2011;33(12):1914–1931.
   PubMed Web of Science ®Google Scholar
• Silverman S, Schepman P, Rice JB, et al. A harm reduction model to assess the impact of new treatments for pain over standard of care among patients with osteoarthritis. J Manag Care Spec Pharm. 2021;27(12):1652–1660.
   PubMed Web of Science ®Google Scholar
• Nalamachu S, Pergolizzi JV, Raffa RB, et al. Drug-drug interaction between NSAIDS and low-dose aspirin: a focus on cardiovascular and GI toxicity. Expert Opin Drug Saf. 2014;13(7):903–917.
   PubMed Web of Science ®Google Scholar
• Makris UE, Kohler MJ, Fraenkel L. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol. 2010;37(6):1236–1243.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jordan JM. Epidemiology of osteoarthritis [published correction appears. Clin Geriatr Med. 2010;26(3):355–369.
   PubMed Web of Science ®Google Scholar